Dorian Bevec is a German molecular biologist, Chief Scientific Officer and co-founder at Mondobiotech.^[1] He was born on May 21, 1957, in Zagreb, FPR Yugoslavia.

Education

• 1980 B.Sc. in general biology, Justus-Liebig-University,^[2] Giessen, Germany
• 1983 M.Sc. in biology, Justus-Liebig-University, Giessen, Germany
• 1984 Visiting Scientist at the Basel Institute for Immunology, Lab. Michael Steinmetz, Basel, Switzerland
• 1983–1985 Scientist at the Institute of Virology, Justus-Liebig-University, Giessen, Germany
• 1985–1988 Scientist at the Laboratory for Molecular Biology of the Ludwig Maximilian University of Munich, Germany
• 1988–1989 Post-doctoral Research Fellow at Sandoz Research Institute, Vienna, Austria
• 1989 Ph.D. in biology, Ludwig Maximilians-University, Munich, Germany

Scientific career

From 1989 to 1990 he was laboratory head at the Department of Immunopharmacology at Sandoz Research Institute, Vienna, Austria, and, after a year as visiting scientist at the Memorial Sloan-Kettering Cancer Center, Laboratory Head, Department of Anti-Retroviral Therapy at Sandoz. In 1996, he became Head of the Molecular Biology Group there. In 1997 he received the Dr. habil. in human virology from the University of Vienna. He then joined Novartis Research Institute as Programme Team Head, Department of Immunology, and, in 1999, became Group Leader and Vice President, Research & Head of Platform Technologies at Axxima Pharmaceuticals AG, Martinsried, Germany; in 2001 he co-founded Mondobiotech Group, Stans, Switzerland, where he took the position of Chief Scientific Officer.